1
Motor Deficits in a Novel Optineurin Mouse for Amyotrophic Lateral Sclerosis McKee, C. 1 , Bomze, H. 1 , Rhodes, T. 2,3 , Means, C. 2,3 , Rodriguiz, R.M. 2,3 , Wetsel, W.C. 2,3,4 , Tseng, H.C. 1 1 Department of Ophthalmology, 2 Department of Psychiatry and Behavioral Sciences, 3 Mouse Behavioral and Neuroendocrine Analysis Core Facility, 4 Departments of Cell Biology and Neurobiology Duke Eye Center and Duke University Medical Center, Durham, NC 27710 Introduction Methods Conclusions Mutations in optineurin are associated with familial glaucoma and amyotrophic lateral sclerosis (ALS). The pathophysiological mechanisms of both neurodegenerative diseases are unknown. Optineurin functions in autophagy, TNF-NFκB signal transduction, protein trafficking, and polyubiquitin binding. We hypothesized that ALS-associated optineurin mutations result in a loss-of-function disease mechanism. To test this, we generated an optineurin knockout mouse and compared knockout animals to C57BL/6J controls in motor behavioral tests. This work is supported by a K12-EY016333, K08- EY021520, and National Eye Institute core grant P30EY005722 to the Duke Eye Center. Acknowledgements Using the Cre-LoxP system (Fig 1), “floxed” optineurin mice were generated and backcrossed to a C57BL/6J background for 5-6 generations. When crossed to CMV-Cre, complete genetic deletion of optineurin was confirmed by Western blotting of dissected retinas (Fig. 1). Motor/behavioral tests were performed using 3-4 month old optineurin homozygous knockout (KO) and C57BL/6J (C57) mice. Disclosures The authors have no commercial interests in this work. Results Figure 1. Generation of optineurin knockout (KO) mice LoxP LoxP Cre LoxP Floxed OPTN OPTN Knockout Exon 1 frt frt Neo R ATG OPTN N-term OPTN C-term -/- +/- +/+ GAPDH Although more physically active (open field test), optineurin KO mice exhibited deficits in balance and coordination (rotarod steady speed, foot fault, and pole walk tests) compared to control C57 mice. Consistently, optineurin KO mice required more time in stabilization gait phases (stance & propel), spent less time in a destabilizing phase (swing), and exhibited reduced paw print area and angle. Front paw grip was stronger in optineurin KO compared to control C57 mice. The KO mice also have weaker rear paws than front paws, but were comparable to control mice. Motor impairments observed in our optineurin KO mice suggest they may be useful as animal models to study ALS. Diameter +/+ (C57) -/- (KO) 28 mm 0% 18.2% 18 mm 10% 63.6% a 12 mm 40% 36.4% 9 mm 30% 63.6% b A p < 0.011, b p = 0.122 Figure 2. Open Field Tests Figure 3. Rotarod Accelerating and Steady Speed Tests Figure 4. Foot Fault Tests Figure 5. Grip Strength Tests Results Results Results Figure 6. Pole Walk Tests Figure 7. Forced Gait Analysis Figure 8. Forced Gait Phases Open Field Test Statistical Difference Vertical Activity -/- (KO) showed more vertical postures Repetitive Activity No difference Lapping/ Circling No difference Thigmotaxis No difference Distance in center -/- (KO) more active In center Time spent in center No difference Percent of C57 (n=10) and KO (n=11) mice which required more than 1 trial to walk across pole Mean ± S.E.M, n = 10 for C57, n = 9 for KO * p < 0.05 by Repeated Measures Analyses of Variance (RMANOVA) Mean ± S.E.M, n = 10 for C57, n = 9 for KO, p = 0.077, ** p = 0.011 Repeated Measures Analyses of Variance (RMANOVA) Mean ± S.E.M, n = 10 for C57, n = 9 for KO, * p = 0.005, ** p = 0.001,*** p = 0.023 Repeated Measures Analyses of Variance (RMANOVA) * * * * ** *** Mean ± S.E.M, n = 10 for C57, n = 9 for KO, * p < 0.001 by Repeated Measures Analyses of Variance (RMANOVA) * * ** * Mean ± S.E.M, n = 10 for C57, n = 11 for KO, * p = 0.003, ** p = 0.001 Repeated Measures Analyses of Variance (RMANOVA) Mean ± S.E.M, n = 10 for C57, n = 9 for KO * p = 0 .03, ** p < 0.001 Repeated Measures Analyses of Variance (RMANOVA) ** * * Mean ± S.E.M, n = 10 for C57, n = 9 for KO * p = 0.018, ** p = 0.009 by t-test ** * * **

SfN OPTN KO ALS poster 111414

Embed Size (px)

Citation preview

TEMPLATE DESIGN © 2008

www.PosterPresentations.com

Motor Deficits in a Novel Optineurin Mouse for Amyotrophic Lateral Sclerosis

McKee, C.1, Bomze, H.1, Rhodes, T.2,3, Means, C.2,3, Rodriguiz, R.M.2,3, Wetsel, W.C.2,3,4, Tseng, H.C.1

1Department of Ophthalmology, 2Department of Psychiatry and Behavioral Sciences, 3Mouse Behavioral and Neuroendocrine Analysis Core Facility, 4Departments of Cell Biology and Neurobiology

Duke Eye Center and Duke University Medical Center, Durham, NC 27710

Introduction

Methods

Conclusions

Mutations in optineurin are associated with

familial glaucoma and amyotrophic lateral

sclerosis (ALS).

The pathophysiological mechanisms of both

neurodegenerative diseases are unknown.

Optineurin functions in autophagy, TNF-NFκB

signal transduction, protein trafficking, and

polyubiquitin binding.

We hypothesized that ALS-associated optineurin

mutations result in a loss-of-function disease

mechanism.

To test this, we generated an optineurin knockout

mouse and compared knockout animals to

C57BL/6J controls in motor behavioral tests.

This work is supported by a K12-EY016333, K08-

EY021520, and National Eye Institute core grant

P30EY005722 to the Duke Eye Center.

Acknowledgements

Using the Cre-LoxP system (Fig 1), “floxed”

optineurin mice were generated and backcrossed

to a C57BL/6J background for 5-6 generations.

When crossed to CMV-Cre, complete genetic

deletion of optineurin was confirmed by Western

blotting of dissected retinas (Fig. 1).

Motor/behavioral tests were performed using 3-4

month old optineurin homozygous knockout

(KO) and C57BL/6J (C57) mice.

Disclosures

The authors have no commercial interests in this work.

Results

Figure 1. Generation of optineurin

knockout (KO) mice

Lo

xP

Lo

xP

Cre

Lo

xP

Floxed OPTN

OPTN

Knockout

Exon 1

frt

frt NeoR

ATG

OPTN N-term

OPTN C-term

-/- +/- +/+

GAPDH

Although more physically active (open field

test), optineurin KO mice exhibited deficits in

balance and coordination (rotarod steady speed,

foot fault, and pole walk tests) compared to

control C57 mice.

Consistently, optineurin KO mice required

more time in stabilization gait phases (stance &

propel), spent less time in a destabilizing phase

(swing), and exhibited reduced paw print area

and angle.

Front paw grip was stronger in optineurin KO

compared to control C57 mice. The KO mice

also have weaker rear paws than front paws,

but were comparable to control mice.

Motor impairments observed in our optineurin

KO mice suggest they may be useful as animal

models to study ALS.

Diameter +/+ (C57) -/- (KO)

28 mm 0% 18.2%

18 mm 10% 63.6%a

12 mm 40% 36.4%

9 mm 30% 63.6%b

A p < 0.011, b p = 0.122

Figure 2. Open Field Tests

Figure 3. Rotarod Accelerating and Steady Speed Tests

Figure 4. Foot Fault Tests

Figure 5. Grip Strength Tests

Results Results Results

Figure 6. Pole Walk Tests

Figure 7. Forced Gait Analysis

Figure 8. Forced Gait Phases

Open Field Test Statistical Difference

Vertical Activity -/- (KO) showed more vertical postures

Repetitive Activity No difference

Lapping/ Circling No difference

Thigmotaxis No difference

Distance in center -/- (KO) more active In center

Time spent in center No difference

Percent of C57 (n=10) and KO (n=11) mice which

required more than 1 trial to walk across pole

Mean ± S.E.M, n = 10 for C57, n = 9 for KO * p < 0.05 by Repeated Measures Analyses of Variance (RMANOVA)

Mean ± S.E.M, n = 10 for C57, n = 9 for KO,

p = 0.077, ** p = 0.011

Repeated Measures Analyses of Variance (RMANOVA)

Mean ± S.E.M, n = 10 for C57, n = 9 for KO, * p = 0.005, ** p = 0.001,*** p = 0.023

Repeated Measures Analyses of Variance (RMANOVA)

* *

*

*

**

***

Mean ± S.E.M, n = 10 for C57, n = 9 for KO, * p < 0.001 by Repeated Measures Analyses of Variance (RMANOVA)

* *

** *

Mean ± S.E.M, n = 10 for C57, n = 11 for KO, * p = 0.003, ** p = 0.001

Repeated Measures Analyses of Variance (RMANOVA)

Mean ± S.E.M, n = 10 for C57, n = 9 for KO * p = 0 .03, ** p < 0.001

Repeated Measures Analyses of Variance (RMANOVA)

**

*

*

Mean ± S.E.M, n = 10 for C57, n = 9 for KO * p = 0.018, ** p = 0.009 by t-test

** *

*

**